Pure Global
NCT06151821

Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control

Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control: A Randomized Controlled Trial Among Hospitalized Type 1 Adolescent Diabetic Patients
Shifa International Hospital·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Type 1 Diabetes Mellitus
Drug/Device/Intervention
Guided meditation
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Shifa International Hospital
Location
Lahore, Pakistan
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Oct 03, 2023
Enrollment
68 participants
Primary outcome

Diabetes distress scale

Summary

The study aims to investigate the effects of Guided Meditation on diabetes-related distress
 and glycemic control in hospitalized Type 1 adolescent diabetic patients. The study will
 employ a randomized controlled trial design, with participants randomly assigned to either
 the intervention group (receiving Guided Meditation sessions) or the control group (receiving
 standard care). The primary outcomes measured will be diabetes-related distress levels and
 glycemic control (HbA1c levels).

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06151821
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06151821 through Pure Global AI's free database. This phase not specified trial is sponsored by Shifa International Hospital and is currently Completed. The study focuses on Type 1 Diabetes Mellitus. Target enrollment is 68 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.